Quartz 5
Search
Search
Dark mode
Light mode
Explorer
breast-cancer
40 items with this tag.
Jul 18, 2026
HER2低表达乳腺癌
entity
breast-cancer
her2-low
Jul 18, 2026
2026 ASCO：转移性乳腺癌的多样治疗方案与共同难题
official-account
breast-cancer
metastatic-breast-cancer
antibody-drug-conjugate
maintenance-therapy
Jul 18, 2026
Loi×Salgado×Galluzzi最新NRI：乳腺癌免疫治疗，下一站不是“加PD-1”，而是重画免疫地图
official-account
breast-cancer
tumor-immunology
tumor-infiltrating-lymphocytes
immune-escape
Jul 18, 2026
细胞因子：驱动乳腺癌转移的“隐形推手”？系统综述揭示靶向新策略
official-account
breast-cancer
cytokines
epithelial-mesenchymal-transition
incomplete-capture
Jul 18, 2026
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer
group-study
breast-cancer
single-cell-rna-seq
cdk4-6-inhibitor
Jul 18, 2026
Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion
group-study
breast-cancer
dcis
spatial-transcriptomics
clonal-evolution
tumor-microenvironment
Jul 18, 2026
上皮-间质转化
concept
emt
metastasis
breast-cancer
Jul 17, 2026
乳腺癌
breast-cancer
entity
Jul 17, 2026
肿瘤浸润淋巴细胞
entity
tumor-infiltrating-lymphocytes
til
breast-cancer
Jul 17, 2026
gBRCA1-2与非gBRCA人群的PARP抑制剂证据
comparison
parp-inhibitor
brca
hrd
breast-cancer
Jul 17, 2026
SUBITO试验：III期HER2阴性HRD乳腺癌，强化化疗+干细胞救援是否仍优于含铂化疗+Olaparib？
official-account
breast-cancer
homologous-recombination-deficiency
olaparib
randomized-trial
Jul 17, 2026
乳腺癌患者德曲妥珠单抗(T-DXd)耐药后怎么办？MSK团队大队列研究给出破解方案
official-account
breast-cancer
t-dxd
antibody-drug-conjugate
drug-resistance
Jul 17, 2026
乳腺癌 ADC 组会讲解笔记——从精准递送到肿瘤微环境重编程
group-study
presentation
breast-cancer
antibody-drug-conjugate
Jul 17, 2026
Evolving antibody-drug conjugates in breast cancer from precision delivery to tumor microenvironment reprogramming
group-study
breast-cancer
antibody-drug-conjugate
Jul 17, 2026
PARP Inhibitors for Breast Cancer Treatment: A Review
group-study
breast-cancer
review
parp-inhibitor
Jul 17, 2026
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph Nodes
group-study
breast-cancer
lymph-node-metastasis
multi-omics
phosphoproteomics
Jul 17, 2026
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial
group-study
breast-cancer
neoadjuvant-treatment
surgery-omission
vacuum-assisted-biopsy
phase-2
Jul 15, 2026
Alpelisib
entity
drug
pi3k-alpha-inhibitor
breast-cancer
Jul 15, 2026
CDK4/6抑制剂
drug-class
cdk4-6-inhibitor
breast-cancer
Jul 15, 2026
HR阳性HER2阳性乳腺癌
entity
breast-cancer
hr-positive
her2-positive
Jul 15, 2026
HR阳性HER2阴性转移性乳腺癌
breast-cancer
hr-positive
her2-negative
metastatic
Jul 15, 2026
PI3K抑制剂
drug-class
pi3k-inhibitor
breast-cancer
Jul 15, 2026
PIK3CA突变乳腺癌
breast-cancer
pik3ca
molecular-subtype
Jul 15, 2026
PI3K抑制剂耐药的PTEN反馈与自噬缺陷代谢脆弱性
comparison
pi3k-inhibitor
resistance
breast-cancer
Jul 15, 2026
Extracellular matrix rigidity controls breast cancer metastasis via TYK2-mediated mechanotransduction
group-study
breast-cancer
tnbc
mechanotransduction
tyk2
metastasis
Jul 15, 2026
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models
group-study
breast-cancer
tnbc
parp-inhibitor
resistance
Jul 15, 2026
Molecular classification of hormone receptor-positive/HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies
group-study
hr-positive
her2-positive
breast-cancer
molecular-subtyping
neoadjuvant-treatment
Jul 15, 2026
Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2− metastatic breast cancer: clinical and molecular perspectives
group-study
breast-cancer
review
cdk4-6-inhibitor
Jul 15, 2026
P005 组会讲解笔记——单细胞 RNA 测序预测 CDK4/6 抑制剂进展
group-study
presentation
breast-cancer
single-cell-rna-seq
Jul 15, 2026
P006 组会讲解笔记——CDK4/6 抑制剂耐药综述
group-study
presentation
breast-cancer
cdk4-6-inhibitor
Jul 15, 2026
P008 组会讲解笔记——乳腺癌 PARP 抑制剂治疗
group-study
presentation
breast-cancer
parp-inhibitor
Jul 15, 2026
P009 组会讲解笔记——FGFR3–PARP1 磷酸化与 PARP 抑制剂耐药
group-study
presentation
breast-cancer
parp-inhibitor
resistance
Jul 15, 2026
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
group-study
review
breast-cancer
hr-positive
pi3k-akt-mtor
Jul 15, 2026
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer
group-study
breast-cancer
basic-research
cdk4-6-inhibitor
Jul 15, 2026
USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer
group-study
breast-cancer
pi3k-inhibitor
pten
resistance
Jul 15, 2026
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
group-study
breast-cancer
pi3k-inhibitor
autophagy
metabolism
Jul 15, 2026
乳腺癌研究 papers：老师文献点评与阅读导引
group-study
teaching-synthesis
literature-digest
teacher-commentary
breast-cancer
Jul 15, 2026
Multiomic integration reveals subtype-specific predictors of neoadjuvant treatment response in breast cancer
group-study
breast-cancer
neoadjuvant-treatment
multi-omics
machine-learning
Jul 15, 2026
Circulating Tumor DNA in Early Breast Cancer: A Review
group-study
breast-cancer
ctdna
mrd
liquid-biopsy
review
Jul 15, 2026
CDK4/6抑制剂耐药
drug-resistance
cdk4-6-inhibitor
breast-cancer